Comment on generalizability of GLP-1 RA CVOTs in US T2D population
- PMID: 30986012
Comment on generalizability of GLP-1 RA CVOTs in US T2D population
Abstract
Previous research overstated the generalizability of the Exenatide Study of Cardiovascular Event Lowering trial results by omitting the restriction on the percentage of patients without a prior cardiovascular event.
Comment in
-
Authors' reply to "Comment on generalizability of GLP-1 RA CVOTs in US T2D population".Am J Manag Care. 2019 Apr;25(4):171-172. Am J Manag Care. 2019. PMID: 30986013
Comment on
-
Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials enrollment criteria to the US type 2 diabetes population.Am J Manag Care. 2018 Apr;24(8 Suppl):S146-S155. Am J Manag Care. 2018. PMID: 29693361
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical